Intuitive Surgical (NASDAQ:ISRG) Shares Gap Down - Should You Sell?

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $608.66, but opened at $581.90. Intuitive Surgical shares last traded at $584.78, with a volume of 1,014,956 shares changing hands.

Analyst Ratings Changes

A number of research firms have issued reports on ISRG. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday. BTIG Research upped their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a report on Tuesday, November 26th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research note on Thursday, December 5th. Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research report on Friday. Finally, The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $583.83.

Intuitive Surgical Trading Down 4.0 %

The company's 50-day moving average is $546.03 and its 200 day moving average is $503.38. The stock has a market capitalization of $208.03 billion, a PE ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 270 shares of the business's stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company's stock, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 42,475 shares of company stock worth $22,070,807. 0.90% of the stock is owned by corporate insiders.

Institutional Trading of Intuitive Surgical

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Mirador Capital Partners LP increased its stake in shares of Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock worth $1,732,000 after purchasing an additional 50 shares in the last quarter. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the 4th quarter worth about $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $82,517,000. Exome Asset Management LLC raised its holdings in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, Consolidated Planning Corp lifted its position in shares of Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock valued at $3,979,000 after acquiring an additional 1,198 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.